Medicine & Life Sciences
lamivudine drug combination abacavir
80%
Emtricitabine
71%
Tenofovir
63%
Fats
37%
Extremities
37%
HIV
34%
Lamivudine
22%
Reverse Transcriptase Inhibitors
22%
Nucleosides
19%
Thymidine
18%
Interleukin-6
9%
Lipodystrophy
8%
Glucose
7%
Subcutaneous Fat
7%
Lower Extremity
5%
Population
4%
Linear Models
4%
Body Mass Index
4%
Biomarkers
4%
Demography
4%
Therapeutics
2%
Agriculture & Biology
abacavir
100%
lamivudine
91%
lipids
26%
RNA-directed DNA polymerase
19%
nucleosides
17%
thymidine
16%
medical history
9%
body mass index
6%
glucose
6%
interleukin-6
6%
demography
5%
biomarkers
5%
therapeutics
4%
duration
3%
dosage
2%
methodology
1%
Chemistry
Fat
49%
RNA Directed DNA Polymerase Inhibitor
28%
Thymidine
18%
Glucose
8%
Antiretroviral
7%
Biological Marker
5%
Metabolic
4%
Dose
4%